[1] In moderate deficiencies, feeling tired, feeling faint, mouth ulcers, rapid breathing, upset stomach, pallor, hair loss, decreased ability to think and joint pain and the beginning of neurological symptoms, including abnormal sensations such as, numbness and tingling, and tinnitus may occur
Evaluating the properties of Dihexa may examine how peptide-derived compounds behave in controlled experimental environments, including transport across biological barriers
The peptide has shown activity in models of neurological injury, though again, these results are primarily from animal studies rather than human trials
Efficacy and effectiveness of incretin-based therapies in body weight reduction Randomized controlled trials (RCT) Liraglutide, titrated up to 3.0 mg administered subcutaneously once daily (OD), was the first incretin-based AOM to be developed and launched on the market
Improved sleep may reduce pain sensitivity and fatigue